SKYLINEDX ANNOUNCES NEW STUDY DEMONSTRATING ENHANCED RISK STRATIFICATION FOR SENTINEL LYMPH NODE BIOPSY IN HEAD AND NECK MELANOMA USING THE ADVANCED MERLIN CP-GEP TEST

SkylineDx Netherlands United States of America United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/skylinedx-announces-new-study-demonstrating-enhanced-risk-stratification-for-sentinel-lymph-node-biopsy-in-head-and-neck-melanoma-using-the-advanced-merlin-cp-gep-test-302398916.html